Cyclacel Pharma (CYCC) Prices 1.807M Share Common Offering at $7/Sh

Go back to Cyclacel Pharma (CYCC) Prices 1.807M Share Common Offering at $7/Sh

After-Hours Stock Movers 03/11: (CFRX) (NVAX) (FNKO) Higher; (MRKR) (POSH) (ULTA) Lower (more...)

March 11, 2021 5:37 PM EST

Today's After-Hours Stock Movers

ContraFect Corporation (Nasdaq: CFRX) 36.2% HIGHER; has been awarded a cost-share contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS). Under the terms of the contract, the Company will receive $9.8 million in initial funding and up to an additional $77.0 million. The initial funding will be used to support ContraFects ongoing pivotal Phase 3 DISRUPT (Direct Lysis of Staph aureus Resistant Pathogen Trial)... More

Cyclacel Pharmaceuticals (CYCC) to Offer Common Stock

March 11, 2021 4:01 PM EST

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) announced today that it intends to offer shares of its common stock for sale in an underwritten public offering. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 15%... More